T(9;22)

Clinical trials for T(9;22) explained in plain language.

Never miss a new study

Get alerted when new T(9;22) trials appear

Sign up with your email to follow new studies for T(9;22), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy shows promise against Hard-to-Treat leukemia

Disease control Recruiting now

This study tests a combination of two drugs, blinatumomab and ponatinib, along with standard chemotherapy, in people with a specific type of acute lymphoblastic leukemia (ALL) that has a genetic change called the Philadelphia chromosome. The goal is to see if this mix can better …

Matched conditions: T(9;22)

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 12:35 UTC

T(9;22)

Get alerted when new T(9;22) trials appear

New combo therapy shows promise against Hard-to-Treat leukemia